JFG
TRML

Jefferies Financial Group’s Tourmaline Bio TRML Stock Holding History

Jefferies Financial Group’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,363
Closed -$830K – 2076
2025
Q3 		$830K Buy
+17,363
New +$482K ﹤0.01% 932

Jefferies Financial Group's TRML Position: Q4 2025 in Review

Jefferies Financial Group sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 17,363 shares — an estimated $830K sold.

Jefferies Financial Group first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $830K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Jefferies Financial Group reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 17,363 Tourmaline Bio shares in Q4 2025, an estimated $830K.
  • Jefferies Financial Group first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Jefferies Financial Group's Tourmaline Bio position peaked at $830K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Jefferies Financial Group's 13F filing for Q4 2025, filed 9 Feb 2026.